Loading provider…
Loading provider…
Hematology & Oncology Physician in Augusta, GA
NPI: 1073775722Primary Practice Location
WELLSTAR MCG HEALTH, AFFILIATED WITH MED COL
1120 15th St, Augusta, GA
Primary Employer
Wellstar Medical Group, LLC
wellstar.org
HQ Phone
Get MD Jigarkumar's Phone NumberMobile
Get MD Jigarkumar's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardGA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 296 | 787 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 162 | 417 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 67 | 84 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 59 | 59 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 44 | 153 |
Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition.
Authors: Sodji, Quaovi, Klein, Kandy, Sravan, Kavuri, Parikh, Jigarkumar
Journal: J Immunother Cancer
Publication Date: 2017-08-15
Authors: Cole Giller, Thomas Samuel, Anand Jillella
Journal: J Neurol Surg A Cent Eur Neurosurg
Publication Date: 2013-02-20
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebo, DRUG: Cabozantinib, DRUG: CB-839
Lead Sponsor: Innocrin Pharmaceutical
Intervention / Treatment: DRUG: Seviteronel
Lead Sponsor: Seagen Inc.
Intervention / Treatment: DRUG: placebo, DRUG: capecitabine, DRUG: tucatinib, DRUG: trastuzumab